Anticancer drug restores hearing in some patients with neurofibromatosis
16-Mar-2016 -
In a small clinical study with an anticancer drug that halts blood vessel growth, a handful of people with neurofibromatosis type 2 (NF2) and hearing loss had restoration of hearing.
An estimated one in 25,000 people is born with NF2, a hereditary tumor syndrome in which virtually everyone ...
bevacizumab
hearing loss
neurofibromatosis